Pain Medicine, Interventional Pain Medicine · Louisville, KY
NPI
1457356263
Since 2005
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
400 Executive Park
Louisville, KY, 40207
Phone (502) 855-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$514K
275,231 services
Medicare patients, 2024
540
Average age 70
Drug cost, 2024
$1.1M
10,756 prescriptions
Company payments, 2025
$626
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary L Reasor was code J1171 (injection, hydromorphone, 0.1 mg), 221,797 times for 31 patients. In total Gary L Reasor billed 275,231 services in 91 codes, and Medicare paid $514K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1171 Injection, hydromorphone, 0.1 mg | Office | 221,797 | 31 | $0.07 | $15K |
| J1170 Injection, hydromorphone, up to 4 mg | Office | 22,410 | 51 | $3.03 | $68K |
| J3010 Injection, fentanyl citrate, 0.1 mg | Office | 11,866 | 192 | $0.67 | $8,002 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 11,348 | 144 | $0.10 | $1,138 |
| 99213 Office E&M - Established | Office | 1,587 | 463 | $52.58 | $83K |
| 80307 Drug Tests | Office | 1,022 | 483 | $58.71 | $60K |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 733 | 184 | $0.11 | $77.16 |
| 62369 Musculoskeletal | Office | 394 | 91 | $52.71 | $21K |
| J0475 Injection, baclofen, 10 mg | Office | 194 | 18 | $137.84 | $27K |
| 99152 Anesthesia | Office | 178 | 115 | $30.27 | $5,388 |
| 99214 Office E&M - Established | Office | 122 | 66 | $79.18 | $9,660 |
| 62323 Nerve Block Injection - Back | Office | 99 | 64 | $151.51 | $15K |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 93 | 78 | $4.19 | $390 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 81 | 68 | $403.84 | $33K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 76 | 64 | $225.89 | $17K |
By year: 2022 $565K for 55,807 services; 2023 $585K for 51,863 services; 2024 $514K for 275,231 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 1,022 | 483 | $58.71 | $60K |
Medicare prescription drug claims, 2024
In 2024, the drug Gary L Reasor prescribed most often to Medicare patients was Oxycodone Hcl, with 2,332 prescriptions and refills. In total Gary L Reasor wrote 10,756 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 2,332 | 2,334 | 261 | $112K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,150 | 2,158 | 284 | $59K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,041 | 2,042 | 261 | $75K |
| Morphine Sulfate Er Morphine Sulfate | 510 | 520 | 58 | $28K |
| Fentanyl Generic | 434 | 434 | 47 | $73K |
| Tizanidine Hcl Generic | 425 | 531 | 71 | $4,776 |
| Hydromorphone Hcl Generic | 344 | 344 | 51 | $11K |
| Oxycontin Oxycodone Hcl | 259 | 259 | 28 | $318K |
| Cyclobenzaprine Hcl Generic | 226 | 288 | 46 | $998 |
| Gabapentin Generic | 190 | 206 | 55 | $2,854 |
| Baclofen Generic | 184 | 251 | 41 | $1,865 |
| Methadone Hcl Generic | 178 | 178 | 27 | $4,791 |
| Morphine Sulfate Generic | 162 | 162 | 25 | $9,285 |
| Xtampza Er Oxycodone Myristate | 151 | 151 | 18 | $206K |
| Promethazine Hcl Generic | 106 | 109 | 17 | $1,002 |
Brand drugs: 694 claims; generic drugs: 10,062 claims; opioid claims: 8,752.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary L Reasor $626 ($626 in general payments such as food, travel and fees) from 9 companies. The largest payer was Medtronic, Inc. with $193.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.